Introduction to JAK/STAT signaling and the vasculature
Author:
- Mario B. MarreroMMMario B. Marrero
- 1 November 2005
- journal article
- editorial
- Published by Elsevier in Vascular Pharmacology
- Vol. 43 (5) , 307-309
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiologyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Endothelial DysfunctionJournal of the American Society of Nephrology, 2004
- Angiotensin-Converting Enzyme Inhibitors versus AT1 Receptor Antagonist in Cardiovascular and Renal ProtectionJournal of the American Society of Nephrology, 2004
- Cytokine G-protein signaling crosstalk in cardiomyocytes: Attentuation of Jak-STAT activation by endothelin-1Molecular and Cellular Biochemistry, 2002
- STATs: transcriptional control and biological impactNature Reviews Molecular Cell Biology, 2002
- Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucoseKidney International, 2002
- Hyperglycemia Enhances Angiotensin II-induced Janus-activated Kinase/STAT Signaling in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1999
- Dependence on the Motif YIPP for the Physical Association of Jak2 Kinase with the Intracellular Carboxyl Tail of the Angiotensin II AT1 ReceptorJournal of Biological Chemistry, 1997
- SYMPOSIUM: Experimental Biology 1995 Role of Mesangial Cell Ion Transport in Glomerular Physiology and Disease: ANGIOTENSIN II‐INDUCED TYROSINE PHOSPHORYLATION IN MESANGIAL AND VASCULAR SMOOTH MUSCLE CELLSClinical and Experimental Pharmacology and Physiology, 1996
- Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptorNature, 1995